Chronic Inflammation Clinical Trials

9 recruitingLast updated: June 20, 2026

There are 9 actively recruiting chronic inflammation clinical trials across 5 countries. Studies span Phase 2, Not Applicable, Phase 1. Top locations include Scottsdale, Arizona, United States, Denver, Colorado, United States, Eau Claire, Wisconsin, United States. Updated daily from ClinicalTrials.gov.


Chronic Inflammation Trials at a Glance

9 actively recruiting trials for chronic inflammation are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Scottsdale, Denver, and Eau Claire. Lead sponsors running chronic inflammation studies include Mayo Clinic, HoHo Biotech, and Asger Lund, MD.

Browse chronic inflammation trials by phase

Treatments under study

About Chronic Inflammation Clinical Trials

Looking for clinical trials for Chronic Inflammation? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Inflammation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Inflammation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

Obesity and OverweightHIVChronic Inflammation
University of Hawaii12 enrolled1 locationNCT06935838
Recruiting
Phase 1

SynKIR-310 for Relapsed/Refractory B-NHL

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma+23 more
Verismo Therapeutics36 enrolled5 locationsNCT06544265
Recruiting
Phase 2

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Recurrent Grade 3b Follicular LymphomaRefractory Grade 3b Follicular LymphomaRecurrent Transformed Non-Hodgkin Lymphoma+28 more
Mayo Clinic41 enrolled7 locationsNCT06834373
Recruiting

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation
Mayo Clinic60 enrolled1 locationNCT04232566
Recruiting
Phase 2

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Type 1 DiabetesInsulin SensitivityChronic Inflammation
Asger Lund, MD26 enrolled1 locationNCT07247734
Recruiting

MicroRNA Regulation of Chronic Inflammation During Aging

Chronic Inflammation
University of Utah40 enrolled1 locationNCT05392582
Recruiting

Pilot Study of the Human Metagenome in Metabolic Diseases

SarcopeniaObesityMetabolic Syndrome+2 more
Sengkang General Hospital600 enrolled1 locationNCT06363253
Recruiting
Not Applicable

Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study

Long COVIDChronic Inflammation
University of Luxembourg20 enrolled1 locationNCT06522750
Recruiting
Phase 2

To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases

Chronic DiseaseChronic Inflammation
HoHo Biotech60 enrolled2 locationsNCT06401785